| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 17,042 | 19,122 | 13,263 | | Cost of Revenue | (10,118) | 6,106 | 4,012 | | | Gross Profit | 27,160 | 13,016 | 9,251 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 24,796 | 11,151 | 8,910 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,364 | 1,865 | 341 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 110 | (34) | 180 | | Earnings Before Interest And Taxes | 2,474 | 1,831 | 521 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 2,474 | 1,831 | 521 | | Income Tax Expense | 1,578 | 686 | 608 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 896 | 1,145 | (87) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 896 | 1,145 | (87) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $896 | $1,145 | ($87) |
|
0.51% Nasdaq 
Income Statement
